Researchers question the use of “cancer” for certain prostate conditions

A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate “cancer” at all.

Colorado DOR Natural Medicine Division Listening Sessions: Part 1 – Psychedelic Alpha

*** Listening Session #5 – Cultivation and Manufacturing Practices Part 1 Following formalities, Dominique Mendiola gave an overview of DOR’s statutory requirements under Title 44

November 1, 2023

Unlocking Alzheimer’s secrets: Study pinpoints APOE4’s harmful effect on lipids

UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have made a new discovery about

February 10, 2024

Competition enforcement led to fairer prices, innovative products — EC report

Antitrust and merger enforcement in Europe has led to fairer prices for medicines and kept markets competitive over the past several years, according to a

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.